Position in NVS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$4,508,834
-$70,763 QoQ
Shares Held
28,770
-4.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#281
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Moors & Cabot, Inc. holds $115,416,483 across 14 Drug Manufacturers - General names. NVS ranks #7 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
120,434 | $30,586,622 | |
| 2 | LLY |
ELI LILLY & Co
|
22,840 | $27,394,983 | |
| 3 | ABBV |
AbbVie Inc.
|
70,717 | $17,795,225 | |
| 4 | MRK |
Merck & Co., Inc.
|
94,665 | $12,164,452 | |
| 5 | PFE |
Pfizer Inc
|
307,330 | $7,400,506 | |
| 6 | AMGN |
Amgen Inc
|
14,884 | $5,389,794 | |
| 7 | NVS |
Novartis AG
This page
|
28,770 | $4,508,834 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
62,967 | $3,628,158 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,508,834 | 28,770 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $4,579,597 | 29,981 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $4,082,606 | 29,612 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $3,756,406 | 29,292 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,758,812 | 31,062 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $3,260,455 | 29,247 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $2,711,543 | 27,865 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $3,284,856 | 28,559 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $3,067,006 | 28,809 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,804,396 | 28,992 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $2,982,855 | 29,542 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,983,683 | 29,292 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,930,628 | 29,042 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $2,764,324 | 30,047 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $2,701,823 | 29,782 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $2,350,229 | 30,920 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $2,638,773 | 31,217 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $2,717,178 | 30,965 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,659,262 | 30,402 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $5,070,360 | 62,000 | Shares | Sole | 2021-12-08 | |
| 2021-06-30 | $2,766,123 | 30,317 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,552,005 | 29,855 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $3,186,918 | 33,749 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $2,958,379 | 34,020 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $3,042,838 | 34,839 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,381,073 | 28,879 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||